249 Preclinical efficacy of the PARP inhibitor rucaparib...

249 Preclinical efficacy of the PARP inhibitor rucaparib (CO-338/AG014699/PF-01367338) in pancreatic cancer models with homologous recombination deficiencies (HRD)

Robillard, L., Lin, K., Lopez-Casas, P.P., Hidalgo, M., Harding, T.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70375-2
Date:
November, 2014
File:
PDF, 58 KB
english, 2014
Conversion to is in progress
Conversion to is failed